These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34372955)

  • 1. SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.
    Naesens R; Mertes H; Clukers J; Herzog S; Brands C; Vets P; De Laet I; Bruynseels P; De Schouwer P; van der Maas S; Bervoets K; Hens N; Van Damme P
    Epidemiol Infect; 2021 Aug; 149():e172. PubMed ID: 34372955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.
    Brousseau N; Morin L; Ouakki M; Savard P; Quach C; Longtin Y; Cheng MP; Carignan A; Dufresne SF; Leduc JM; Lavallée C; Gauthier N; Bestman-Smith J; Arrieta MJ; Ishak M; Lévesque S; Martin P; De Serres G
    CMAJ; 2021 Dec; 193(49):E1868-E1877. PubMed ID: 34903591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.
    Poletti P; Tirani M; Cereda D; Guzzetta G; Trentini F; Marziano V; Toso C; Piatti A; Piccarreta R; Melegaro A; Andreassi A; Gramegna M; Ajelli M; Merler S
    JAMA Netw Open; 2021 Jul; 4(7):e2115699. PubMed ID: 34228126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
    Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
    Ladoire S; Goussot V; Redersdorff E; Cueff A; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hanu R; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
    Eur J Cancer; 2021 May; 148():359-370. PubMed ID: 33780664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Survey Among 17 971 Healthcare and Administrative Personnel at Hospitals, Prehospital Services, and Specialist Practitioners in the Central Denmark Region.
    Jespersen S; Mikkelsen S; Greve T; Kaspersen KA; Tolstrup M; Boldsen JK; Redder JD; Nielsen K; Abildgaard AM; Kolstad HA; Østergaard L; Thomsen MK; Møller HJ; Erikstrup C
    Clin Infect Dis; 2021 Nov; 73(9):e2853-e2860. PubMed ID: 33011792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
    Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Seropositivity in Nursing Home Staff and Residents during the First SARS-CoV-2 Wave in Flanders, Belgium.
    De Rop L; Vercruysse H; Alenus U; Brusselmans J; Callens S; Claeys M; De Coene N; Persyn P; Padalko E; Heytens S; Verbakel JY; Cools P
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests.
    van Dam P; Huizing M; Roelant E; Hotterbeekx A; De Winter FHR; Kumar-Singh S; Moons P; Amajoud Z; Vulsteke C; Croes L; Janssens A; Berneman Z; Prenen H; Meuris L; Vanden Berghe W; Smits E; Peeters M
    Eur J Cancer; 2021 May; 148():328-339. PubMed ID: 33773276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
    Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
    BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 seroprevalence in high-risk health care workers in a Belgian general hospital: evolution from the first wave to the second.
    Wauthier L; Delefortrie Q; Eppe N; Vankerkhoven P; Wolff E; Dekeyser M; Cirriez JM; Grimmelprez A
    Acta Clin Belg; 2022 Dec; 77(6):906-914. PubMed ID: 34789077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
    Adriaenssens N; Scholtes B; Bruyndonckx R; Verbakel JY; De Sutter A; Heytens S; Van den Bruel A; Desombere I; Van Damme P; Goossens H; Buret L; Duysburgh E; Coenen S
    BMJ Open; 2022 Jan; 12(1):e054688. PubMed ID: 35105642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff.
    Martin C; Montesinos I; Dauby N; Gilles C; Dahma H; Van Den Wijngaert S; De Wit S; Delforge M; Clumeck N; Vandenberg O
    J Hosp Infect; 2020 Sep; 106(1):102-106. PubMed ID: 32593608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.
    Self WH; Tenforde MW; Stubblefield WB; Feldstein LR; Steingrub JS; Shapiro NI; Ginde AA; Prekker ME; Brown SM; Peltan ID; Gong MN; Aboodi MS; Khan A; Exline MC; Files DC; Gibbs KW; Lindsell CJ; Rice TW; Jones ID; Halasa N; Talbot HK; Grijalva CG; Casey JD; Hager DN; Qadir N; Henning DJ; Coughlin MM; Schiffer J; Semenova V; Li H; Thornburg NJ; Patel MM; ;
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1221-1226. PubMed ID: 32881855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
    Jacot D; von Rotz U; Blondet F; Aebischer O; Matthieu P; De Rham M; Pantaleo G; Marchetti O; Greub G
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35921229
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.
    Purswani MU; Bucciarelli J; Tiburcio J; Yagudayev SM; Connell GH; Omidiran AA; Hannaway L; Zeana C; Healy M; Yu G; Reich D
    J Hosp Med; 2021 May; 16(5):282-289. PubMed ID: 33929948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children's hospital before second pandemic wave in Germany.
    Neumann M; Aigner A; Rossow E; Schwarz D; Marschallek M; Steinmann J; Stücker R; Koenigs I; Stock P
    World J Pediatr; 2021 Oct; 17(5):484-494. PubMed ID: 34415560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
    Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.